ETFChannel.com
KNTE Description — Kinnate Biopharma Inc

Kinnate is a clinical stage biopharmaceutical company focused on the discovery and development of small molecule kinase inhibitors for genomically defined cancers. Co.'s focus is on three patient populations: those with cancers that harbor known oncogenic drivers with no available targeted therapies; those with genomically well-characterized tumors that have resistance to available treatments; and those whose tumors have acquired resistance over the course of therapy to available treatments. Co.'s product candidates are KIN002787, which is for the treatment of patients with lung cancer, melanoma and other solid tumors; and KIN-3248, which is targeting cancer-associated alterations in FGFR2.

Company Name: 
Kinnate Biopharma Inc
Website: 
www.kinnate.com
Sector: 
Biotechnology
Number of ETFs Holding KNTE: 
15
Total Market Value Held by ETFs: 
$15,295,755
Total Market Capitalization: 
$350,000,000
% of Market Cap. Held by ETFs: 
4.37%
 ETF   KNTE Weight   KNTE Amount 
 IWM   0.01%   $5,038,846         
 VTI   0.00%   $4,822,244         
 IWN   0.02%   $2,268,643         
 VXF   0.00%   $1,633,746         
 VTWO   0.01%   $547,276         
 IWC   0.05%   $464,154         
 VTWV   0.02%   $185,084         
 ITOT   0.00%   $167,575         
 IWV   0.00%   $90,833         
 BIB   0.02%   $28,070         
List of all 15 ETFs holding KNTE »
Quotes delayed 20 minutes

Email EnvelopeFree KNTE Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

Strong Buy (3.75 out of 4)
66th percentile
(ranked higher than approx. 66% of all stocks covered)
Based on data provided by Zacks Investment Research via Quandl.com

ETFs Holding KNTE | Kinnate Biopharma Inc | ETF Channel | www.ETFChannel.com

Copyright © 2010 - 2022, All Rights Reserved Nothing in ETF Channel is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and ETF videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact ETF Channel; Meet Our Editorial Staff.